olaparib
astrazeneca,merck
['vance', 'solo1', 'olaparib', 'brca', 'ovarian']
yet another transformative presentation. 67% of advanced stage brcamut ovarian cancer patients alive at 7 years with maintenance olaparib! this is transformative. for some, cure is here! solo1/gog3004. 
Gyn Oncologist with passion for excellent patient care, clinical trials and drug development. Associate professor @UCSD_OBGYN, views = own